H.R. 1199 · 118th Congress · House

Facilitating Innovative Nuclear Diagnostics Act of 2023

Active· Forwarded by Subcommittee to Full Committee by Voice Vote.
Introduced
Feb 27, 23
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Facilitating Innovative Nuclear Diagnostics Act of 2023

This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2024 and as adjusted based on a specified fee schedule factor in each year thereafter.

Action Timeline

7
  1. MAY 16, 2024•Committee

    Subcommittee Consideration and Mark-up Session Held

  2. MAY 16, 2024•Committee

    Forwarded by Subcommittee to Full Committee by Voice Vote.

  3. MAR 10, 2023•Committee

    Referred to the Subcommittee on Health.

  4. FEB 27, 2023•IntroReferral

    Introduced in House

  5. FEB 27, 2023•IntroReferral

    Introduced in House

  6. FEB 27, 2023•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  7. FEB 27, 2023•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committees

5

Health Subcommittee

hsif14

Referred: May 16, 2024

Active

Health Subcommittee

hsif14

Referred: May 16, 2024

Active

Health Subcommittee

hsif14

Referred: Mar 10, 2023

Active

Ways and Means Committee

hswm00

Referred: Feb 27, 2023

Active

Energy and Commerce Committee

hsif00

Referred: Feb 27, 2023

Active